Edesa Biotech Inc (EDSA)
4.420
-0.05
(-1.09%)
USD |
NASDAQ |
Apr 26, 16:00
Edesa Biotech Total Assets (Quarterly): 7.832M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.832M |
September 30, 2023 | 8.890M |
June 30, 2023 | 9.420M |
March 31, 2023 | 10.67M |
December 31, 2022 | 11.67M |
September 30, 2022 | 11.58M |
June 30, 2022 | 17.54M |
March 31, 2022 | 20.41M |
December 31, 2021 | 12.34M |
September 30, 2021 | 14.58M |
June 30, 2021 | 16.88M |
March 31, 2021 | 24.00M |
December 31, 2020 | 10.29M |
September 30, 2020 | 10.76M |
June 30, 2020 | 8.923M |
March 31, 2020 | 7.633M |
December 31, 2019 | 5.089M |
June 30, 2019 | 7.228M |
March 31, 2019 | 9.151M |
December 31, 2018 | 10.50M |
September 30, 2018 | 11.78M |
June 30, 2018 | 12.80M |
March 31, 2018 | 5.330M |
December 31, 2017 | 6.593M |
September 30, 2017 | 7.72M |
Date | Value |
---|---|
June 30, 2017 | 9.022M |
March 31, 2017 | 10.22M |
December 31, 2016 | 11.47M |
September 30, 2016 | 12.94M |
June 30, 2016 | 8.50M |
March 31, 2016 | 9.429M |
December 31, 2015 | 10.35M |
September 30, 2015 | 10.39M |
June 30, 2015 | 11.21M |
March 31, 2015 | 11.83M |
December 31, 2014 | 13.43M |
August 31, 2014 | 14.47M |
May 31, 2014 | 15.51M |
February 28, 2014 | 16.53M |
November 30, 2013 | 17.44M |
August 31, 2013 | 8.513M |
May 31, 2013 | 2.234M |
February 28, 2013 | 1.401M |
November 30, 2012 | 2.16M |
August 31, 2012 | 1.544M |
May 31, 2012 | 2.512M |
February 29, 2012 | 3.478M |
November 30, 2011 | 4.830M |
August 31, 2011 | 4.751M |
May 31, 2011 | 5.709M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.089M
Minimum
Dec 2019
24.00M
Maximum
Mar 2021
11.99M
Average
10.72M
Median
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Lexaria Bioscience Corp | 6.352M |
Xenon Pharmaceuticals Inc | 964.80M |
ESSA Pharma Inc | 144.49M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.987M |
Shareholders Equity (Quarterly) | 5.845M |